1. Home
  2. SABS vs HTCR Comparison

SABS vs HTCR Comparison

Compare SABS & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • HTCR
  • Stock Information
  • Founded
  • SABS 2014
  • HTCR 2009
  • Country
  • SABS United States
  • HTCR Japan
  • Employees
  • SABS N/A
  • HTCR N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • HTCR EDP Services
  • Sector
  • SABS Health Care
  • HTCR Technology
  • Exchange
  • SABS Nasdaq
  • HTCR Nasdaq
  • Market Cap
  • SABS 15.8M
  • HTCR 12.8M
  • IPO Year
  • SABS N/A
  • HTCR 2022
  • Fundamental
  • Price
  • SABS $1.76
  • HTCR $0.54
  • Analyst Decision
  • SABS Strong Buy
  • HTCR
  • Analyst Count
  • SABS 5
  • HTCR 0
  • Target Price
  • SABS $11.80
  • HTCR N/A
  • AVG Volume (30 Days)
  • SABS 33.1K
  • HTCR 2.5M
  • Earning Date
  • SABS 08-07-2025
  • HTCR 08-13-2025
  • Dividend Yield
  • SABS N/A
  • HTCR 3.64%
  • EPS Growth
  • SABS N/A
  • HTCR N/A
  • EPS
  • SABS N/A
  • HTCR N/A
  • Revenue
  • SABS $377,835.00
  • HTCR $28,947,523.00
  • Revenue This Year
  • SABS N/A
  • HTCR N/A
  • Revenue Next Year
  • SABS N/A
  • HTCR $8.59
  • P/E Ratio
  • SABS N/A
  • HTCR N/A
  • Revenue Growth
  • SABS N/A
  • HTCR 59.42
  • 52 Week Low
  • SABS $1.00
  • HTCR $0.49
  • 52 Week High
  • SABS $5.01
  • HTCR $3.38
  • Technical
  • Relative Strength Index (RSI)
  • SABS 47.99
  • HTCR 46.03
  • Support Level
  • SABS $1.60
  • HTCR $0.54
  • Resistance Level
  • SABS $1.80
  • HTCR $0.53
  • Average True Range (ATR)
  • SABS 0.12
  • HTCR 0.04
  • MACD
  • SABS -0.02
  • HTCR -0.00
  • Stochastic Oscillator
  • SABS 50.00
  • HTCR 30.62

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: